Drugs / ATG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01318915 | Jul 2011 → Jun 2016 | disease related to solid organ transplantation | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01318915 ↗ |
| Route | Intravenous | “1.5 mg/kg IV infusion on day of transplant, and 3 additional on days 2 through 7 after transplant.” NCT01318915 ↗ |